|
Discontinued Operations (Amounts Included in Consolidated Statements of Operations) (Details) (USD $)
|
3 Months Ended | 12 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2013
|
Sep. 30, 2013
|
Jun. 30, 2013
|
Mar. 31, 2013
|
Dec. 31, 2012
|
Sep. 30, 2012
|
Jun. 30, 2012
|
Mar. 31, 2012
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Dec. 31, 2011
|
|
| Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||
| Net sales | $ 1,130,630 | $ 78,738 | $ 597,729 | ||||||||
| Gross profit | 383,000 | 325,000 | 90,000 | 0 | 7,000 | 0 | 60,000 | 12,000 | 797,815 | 78,738 | 597,729 |
| Research and development | 23,710,183 | 16,890,482 | 15,154,365 | ||||||||
| Selling, general and administrative | 15,525,946 | 11,177,559 | 9,547,779 | ||||||||
| Total operating expenses | 13,436,000 | 10,250,000 | 8,546,000 | 7,004,000 | 7,033,000 | 9,069,000 | 5,447,000 | 6,518,000 | 39,236,129 | 28,068,041 | 24,702,144 |
| Other expense, net | (4,261,144) | (1,167,901) | (943,161) | ||||||||
| Income taxes | 0 | 0 | 7,880,143 | ||||||||
| Income from operations | 0 | 0 | 3,329,534 | ||||||||
|
GDS Business and Cardiosonix Subsidiary [Member]
|
|||||||||||
| Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||
| Net sales | 7,684,689 | ||||||||||
| Cost of goods sold | 2,324,427 | ||||||||||
| Gross profit | 5,360,262 | ||||||||||
| Research and development | 564,194 | ||||||||||
| Selling, general and administrative | 308,220 | ||||||||||
| Total operating expenses | 872,414 | ||||||||||
| Other expense, net | (1,084) | ||||||||||
| Income taxes | 1,157,230 | ||||||||||
| Income from operations | $ 3,329,534 | ||||||||||